Keywords = FibroScan
| Number of Articles: 28 | ||||
| 1 | Role of Transient Elastography (Fibroscan) in Early prediction of Hepatitis C Virus Related Hepatocellular Carcinoma | |||
| Articles in Press, Accepted Manuscript , Available Online from 13 January 2023 | ||||
| Mohammed Nagy Mohammed; Mohammed Hassan Al-Nadry; waleed Mohamed Gomaa; Mohamed Mahmoud Abdel-halim; Ashraf Omar Abdelaziz; Mohamed mahmoud Nabeel; Tamer mahmoud elbaz; Rania Lithy; Ahmed Hosni Abdelmaksoud; Hend Ibrahim Shousha | ||||
| 2 | Fibroscan and Low-Density Lipoprotein Versus Non-invasive Markers (APRI test and FIB-4) As Determinants of Severe Liver Fibrosis in Egyptian Diabetic Patients With Non-Alcoholic Fatty Liver Disease. | |||
| Articles in Press, Accepted Manuscript , Available Online from 13 January 2023 | ||||
| esmail anwar esmail; Mohamed Hassan Alnadry; mohamed mousa hegazy; mohamed mahmoud abdel-halim; mohamed hassani barbari | ||||
| 3 | The ratio between red cell distribution width to platelets as predictor for hepatic fibrosis in non alcoholic fatty liver disease in Egyptian patients. | |||
| Volume 41, Issue 2, May and June 2024, Page 168-178 | ||||
| Fatma Mohamed abdelsalam; Amin Mohamed Abd EL-baki; Karim Hussein Elkerdasy; Ghadeer Mohammed Rashad | ||||
| 4 | Simple Predictors of Gastro Esophageal Varices Bleeding in Cirrhotic Patients | |||
| Volume 92, Issue 1, July 2023, Page 5751-5755 | ||||
| 5 | Assessment of hepatic fibrosis in hemodialysis children and adolescents by fibroscan and hyaluronic acid | |||
| Volume 29, Issue 4, July and August 2023, Page 1115-1123 | ||||
| Mayy Abd Alfattah Neemat-Allah; Hosam Fathi Elsaadany; Ahmed Mokhtar Ahmed Ibrahem; Sameh Saber Hegab; Sabreen Reda Mohamed Abdelaziz; Mona Mohammed Mohammed Elsharkawy | ||||
| 6 | Fibroscan in Grading and Prediction of the Risk of Bleeding of Gastro-Esophageal Varices in HCV related Cirrhotic Patients | |||
| Volume 91, Issue 1, April 2023, Page 5157-5161 | ||||
| Mohamed Omar; Zakaria Abdellatif Salama; Yasmin Saad; Mohammed Mostafa Abdelghaffar | ||||
| 7 | Role of Transient Elastography (Fibroscan) in Assessment of Liver Fibrosis in Chronic Hepatitis C Patients | |||
| Volume 26, Issue 3, March 2023, Page 0-0 | ||||
| Shaymaa N. Gad Alla; Tarek H. Khalil | ||||
| 8 | Correlation between Liver function tests, lipid profile and fibroscan in non-alcoholic fatty liver disease | |||
| Volume 6, Issue 1, January 2023, Page 160-165 | ||||
| Ali A. Ghweil; Hassan S. Mahmoud; Mohamed Elsenbesy; Amal Shahat Mohammed | ||||
| 9 | Role of Controlled Attenuation Parameter in Metabolic Associated Fatty Liver Disease Patients | |||
| Volume 12, Issue 3, September 2022, Page 196-207 | ||||
| Yehia M El-Khashab; Tarik I Zaher; Noha E Shaheen; Sameh M Abdel Monem | ||||
| 10 | SERUM VASCULAR CELL ADHESION MOLECULE-1 PREDICTS SIGNIFICANT LIVER FIBROSIS IN NON ALCOHOLIC FATTY LIVER DISEASE | |||
| Volume 51, Issue 2, April 2022, Page 1155-1170 | ||||
| Ahmed Reyad Ibrahim; Mohamed Nabil Raafat; Hendawy Abd El-Moaty Zidan; Abd El-Raof Abd El-Raof Mahmoud | ||||
| 11 | Comparison between Real-Time Tissue Elastography (HI-RTE) and Fibroscan in Assessment of Liver Fibrosis in Chronic HCV Patients | |||
| Volume 90, Issue 3, March 2022, Page 359-366 | ||||
| IMAN RAMZY, M.D.; HANAN ABDEL HAFEZ, M.D.; MOHAMED EL KASSAS, M.D.; KAMAL HASSAN, M.Sc.; MOHAMED HASSANY, M.D.; AISHA ELSHARKAWY, M.D. | ||||
| 12 | Fibrofast and Fibrosis-4 versus Fibroscan as Indicators of Hepatic Fibrosis in Non Alcholic Fatty Liver Disease Patients: A Cross-Sectional Study | |||
| Volume 5, Issue 1, January 2022, Page 58-75 | ||||
| Rehab Badawi; Boshra El-sayed Hussein; Mona Mohamed Watany; Hala Moustafa Elsabagh; Walaa Elkhalawany | ||||
| 13 | Assessment of Fibrosis After Treatment with Direct-Acting Antiviral Drugs with or without Silymarin in Patients with Chronic Hepatitis C Related Liver Disease | |||
| Volume 3, Issue 1, 2021, Page 1-11 | ||||
| 14 | Doppler Ultrasound and Fibroscan Parameters Versus Liver Biopsy in Evaluation of Hepatic Fibrosis in Egyptian Patients with Chronic Hepatitis C | |||
| Volume 11, Issue 2, June 2021, Page 186-198 | ||||
| Nadia Elwan; Manal Hemisa; Hanan Soliman; Mohammed Elhendawy; Shimaa Soliman; Nehad Hawash; Rehab Badawi | ||||
| 15 | Non-invasive Methods in Diagnosis of Nonalcoholic Fatty Liver Disease | |||
| Volume 83, Issue 1, April 2021, Page 1038-1042 | ||||
| Khaled Hemida; Hany Haroun; Inas Elkhedr Mohamed; Mostafa Mahmoud | ||||
| 16 | The Effect of Direct Acting Antiviral Therapy for Hepatitis C- Virus Infected Egyptian Patients on Changes in the Parameters of Liver Fibrosis Progression | |||
| Volume 41, Issue 2, April 2021, Page 203-219 | ||||
| Mohamed A. Elfiki; Mahmoud Farid; Ayman Soliman; Bishoy A. Ibrahim | ||||
| 17 | Erectile function in patients with Liver fibrosis | |||
| Volume 6, Issue 2, March and April 2021, Page 213-217 | ||||
| A.A. Saleh; G.M. Abdel Khalik; M.A. El Jaky; H.R. Askar | ||||
| 18 | Study of Correlation between Fibroscan and Resistin Level in Non-Alcoholic Fatty Liver Disease Patient | |||
| Volume 82, Issue 4, January 2021, Page 695-700 | ||||
| Atef Abo El Soud; Ashraf Dawood; Sherien Abd El-Aziz Bayoumi El-Kashash; Mohsen El Khayat | ||||
| 19 | Role of Colour Doppler Ultrasound in the Diagnosis and Grading of Liver Cirrhosis Compared with Transient Elastograpgy (Fibroscan) | |||
| Volume 5, Issue 1 part (1), January 2020, Page 67-74 | ||||
| E.M. Elshaer; H.M. Khater; A.F. Yousief | ||||
| 20 | Fibrosis Stage as a Predictor of Outcome after Resection for Hepatocellular Carcinoma | |||
| Volume 87, December, December 2019, Page 5201-5206 | ||||
| MAHMOUD H. ALLAM, M.D.; MOHAMED A.S. KOHLA, M.D.; ALIAA SABRY, M.D.; OSAMA HIGAZY, M.D.; WALEED ABOGHARBIA, M.Sc.; ASHRAF ABOGABAL, M.D. | ||||
| 21 | Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt | |||
| Volume 4.1, Issue 1, November 2019, Page 45-52 | ||||
| Gamal Shiha; Alaa Aboud; Doaa Mahmoud Khalil; Asmaa Salama Sieddek | ||||
| 22 | Soluble CD163 as a surrogate marker of fibrosis regression in chronic HCV patients receiving direct antiviral agents | |||
| Volume 6, Issue 7, November 2019, Page 43-55 | ||||
| Amira Isaac; Ahmed Aly Mo'nes; Wesam Essam Aly Wassfy; Hesham Hamdy El-Kilany | ||||
| 23 | Assessment of Liver Stiffness among Chronic Hepatitis C Patients after Oral Antiviral Drugs in Zagazig University Hospitals | |||
| Volume 25, Issue 5, September 2019, Page 630-638 | ||||
| Mohammed Hisham Mounir; Amany Mohammed Ibrahim; Sameh Saber Bayiomy; Hany Mostafa Omar | ||||
| 24 | LIVER STIFFNESS MEASURMENT BY FIBROSCAN FOR PREDICTING THE GRADES OF OESOPHAGEAL VARICES IN HCV CIRRHOTIC PATIENTS | |||
| Volume 45, Issue 3, March 2019, Page 49-68 | ||||
| Mohamed A. Hashish; Mostafa H. Ragab; Hossam A. Mahmoud | ||||
| 25 | The Role of Fibroscan as a Non-Invasive Predictor for Oesophageal Varices in Post HCV Cirrhotic Egyptian Patients With or Without Bilhariziasis | |||
| Volume 72, Issue 8, July 2018, Page 5079-5085 | ||||
| Mohamed Bastawy; Anwar Gomaa El-Sheety; Ahmed Abd El-Aleem; Yasser M. M. El-Dessouky; Ayman Rabie; Sherif Mohammad El-sayed Amine Hegab | ||||
| | ||||
View on SCiNiTO
